- Home
- VOR vs SABR Comparison
VOR vs SABR Comparison
Compare VOR & SABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VOR | SABR |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | 76 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 813.3M | 814.3M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | VOR | SABR |
|---|---|---|
| Price | $14.99 | $1.76 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 1 |
| Target Price | ★ $45.33 | $1.50 |
| AVG Volume (30 Days) | 800.4K | ★ 6.4M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 283.56 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $3,866,956,000.00 |
| Revenue This Year | N/A | $7.51 |
| Revenue Next Year | N/A | $3.46 |
| P/E Ratio | ★ N/A | $83.00 |
| Revenue Growth | N/A | ★ 7.46 |
| 52 Week Low | $0.18 | $0.81 |
| 52 Week High | $49.95 | $3.46 |
Technical Indicators
Market Signals| Indicator | VOR | SABR |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 54.72 |
| Support Level | $13.73 | $1.72 |
| Resistance Level | $16.87 | $1.99 |
| Average True Range (ATR) | 0.98 | 0.11 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 26.56 | 47.06 |
Price Performance
Historical ComparisonAbout VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
About SABR Sabre Corporation
Sabre holds the number-two air booking volume share in the global distribution system industry. The distribution segment represented 80% of total 2025 revenue and airline IT solutions 20% of revenue. The company sold its growing hotel IT solutions division to TPG in 2025 for $960 million in net proceeds. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.